For CLIA, CAP and ISO 15189 laboratories
Method validation,
from plan to signature.
Plan the study. Import the results. Run the statistics. Sign the report.
- Plan
- Data
- Analysis
- Review
- Sign
Acceptance rule
Slope 0.95 to 1.05
Locked before data, plan v1
- Pairs
- 60
- Slope
- 0.970
- 95% CI
- 0.954 to 0.987
- Intercept
- 1.28
Criterion met
Pair 54 residual 12.1 mg/dL
InvestigateComputed live in your browser from 60 synthetic glucose pairs by Passing-Bablok regression.
How a study moves.
-
01
Plan
Slope 0.95 to 1.05Bias within 6 mg/dLApproved, locked -
02
Import
60 rows, 0 errors# CHM-01 CHM-02 1 81.2 78.4 2 124.4 124.5 3 62.2 63.4 -
03
Analyze
-
04
Investigate
171.2 mg/dL original keptRerun on a second analyzer. -
05
Sign
Technical reviewerLaboratory director
The performance specs, mapped to studies.
Unmodified FDA-cleared test, 42 CFR 493.1253(b)(1)
- AccuracyMethod comparisonEP09
- PrecisionRepeatability and within-labEP15
- Reportable rangeLinearity and recoveryEP06
- Reference intervalsTransference, 2 of 20EP28
- Analytical sensitivityDetection limitEP17
- Analytical specificityInterferenceEP07
The statistics, labeled honestly.
See all 36 packages
Validation Studio is in preview. Each laboratory accepts a method before operational use.
Already using Validation Studio?
Sign in